Evidence map›Paper›PMID 38312093›Full record

ArticleAngiology2025

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease.

Gerfried Pesau, Bernhard Zierfuss, Clemens Hoebaus, Renate Koppensteiner, Gerit-Holger Schernthaner

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gerfried PesauDivision of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-2594-5102
Bernhard ZierfussDivision of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.
Clemens HoebausDivision of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-9704-1452
Renate KoppensteinerDivision of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.
Gerit-Holger SchernthanerDivision of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trefoil factor 3 (TFF3) has been studied in processes leading to atherosclerosis. Data are scarce in manifest disease and missing in peripheral artery disease (PAD). This study aims to elucidate TFF3 with disease stages, degrees of atherosclerosis, and outcomes. TFF3 was measured in serum in 364 PAD patients without critical limb ischemia and mild to moderate chronic kidney disease (CKD). Mortality data were retrieved from the Austrian central death registry (median observation 9.6 years). Survival analyses were performed using Cox regression and the Kaplan-Meier method. A negative association between ankle-brachial index and TFF3 (

Indexed as

Peripheral Arterial DiseaseTrefoil Factor-3AgedAged, 80 and overAnkle Brachial IndexAustriaBiomarkersFemaleGlomerular Filtration RateHumansMaleMiddle AgedPredictive Value of TestsPrognosisRegistriesRisk FactorsBiomarkersTFF3 protein, humanTrefoil Factor-3atherosclerosismortalityperipheral artery diseaserenal diseasetrefoil factor 3

Identifiers

PMID38312093
PMCPMC12012275
OpenAlexW4391539004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.